RetinalGenix Technologies (RTGN) Net Cash Flow (2020 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Net Cash Flow came in at -$14594.0 in Q1 2026, down 521.29% year-on-year from $3464.2 in Q1 2025, and down 199.4% quarter-over-quarter from $14682.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Net Cash Flow (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Net Cash Flow across 7 years of filings, most recently posting -$14594.0 for Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$14594.0, down 521.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3531.0 (up 92.43% YoY), and the FY2025 annual result was $8714.0, up 43.8% from the prior year.
- Net Cash Flow came in at -$14594.0 for Q1 2026 at RetinalGenix Technologies, down from $14682.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $50386.0 in Q1 2024 to a low of -$73029.0 in Q4 2024.
- The 5-year median for Net Cash Flow is -$2349.0 (2025), against an average of -$262.35.
- Peak annual rise in Net Cash Flow reached 757.32% in 2024, while the deepest fall reached 165875.0% in 2024.
- RetinalGenix Technologies' Net Cash Flow stood at -$3574.0 in 2022, then soared by 98.77% to -$44.0 in 2023, then slumped by 165875.0% to -$73029.0 in 2024, then jumped by 120.1% to $14682.0 in 2025, then plunged by 199.4% to -$14594.0 in 2026.
- The last three Net Cash Flow figures came in at -$14594.0 (Q1 2026), $14682.0 (Q4 2025), and -$747.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -500.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.19 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 202.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 20.30 Mn |
| 10 | RetinalGenix Technologies | - | - | - | -14,594.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,594.00 |
| Mar 31, 2026 | -14,594.00 |
| Dec 31, 2025 | 14,682.00 |
| Dec 31, 2025 | 14,682.00 |
| Sep 30, 2025 | -747.00 |
| Sep 30, 2025 | -747.00 |
| Jun 30, 2025 | -2,872.00 |
| Jun 30, 2025 | -2,872.00 |
| Mar 31, 2025 | -2,349.00 |
| Mar 31, 2025 | -2,349.00 |
| Dec 31, 2024 | -73,029.00 |
| Dec 31, 2024 | -73,029.00 |
| Sep 30, 2024 | -7,824.00 |
| Sep 30, 2024 | -7,824.00 |
| Jun 30, 2024 | 36,527.00 |
| Jun 30, 2024 | 36,527.00 |
| Mar 31, 2024 | 50,386.00 |
| Mar 31, 2024 | 50,386.00 |
| Dec 31, 2023 | -44.00 |
| Dec 31, 2023 | -44.00 |